"1 Oval" Pill Images
The following drug pill images match your search criteria.
![Pill I 1 White Capsule/Oblong is Naproxen Delayed Release](https://www.drugs.com/images/pills/nlm/317220338.jpg)
1 / 4
Loading
I 1
1 / 2
Loading
AT131
![Pill M 8961 10 mg White Capsule/Oblong is Dextroamphetamine Sulfate Extended Release](https://www.drugs.com/images/pills/custom/pill5090-1/dextroamphetamine-sulfate-extended-release.jpg)
M 8961 10 mg
Dextroamphetamine Sulfate Extended Release
- Strength
- 10 mg
- Imprint
- M 8961 10 mg
- Color
- White
- Shape
- Capsule/Oblong
1 / 3
Loading
AMNEAL 1170
Doxepin Hydrochloride
- Strength
- 25 mg
- Imprint
- AMNEAL 1170
- Color
- White & Yellow
- Shape
- Capsule/Oblong
![Pill MINIPRESS PFIZER 431 White Capsule/Oblong is Minipress](https://www.drugs.com/images/pills/mtm/000694310_PB.jpg)
1 / 3
Loading
MINIPRESS PFIZER 431
![Pill 341 30 mg Orange Capsule/Oblong is Amphetamine and Dextroamphetamine Extended-Release](/img/pillid/no-image-placeholder.png)
341 30 mg
Amphetamine and Dextroamphetamine Extended-Release
- Strength
- 30 mg
- Imprint
- 341 30 mg
- Color
- Orange / Clear
- Shape
- Capsule/Oblong
U16
Acetaminophen and Oxycodone Hydrochloride
- Strength
- 325 mg / 7.5 mg
- Imprint
- U16
- Color
- White
- Shape
- Oval
![Pill HH 172 White Oval is Levetiracetam Extended-Release](https://www.drugs.com/images/pills/mmx/t111455f/levetiracetam-extended-release.jpg)
1 / 3
Loading
HH 172
![Pill SG 461 Blue Oval is Carbidopa and Levodopa Extended-Release](https://www.drugs.com/images/pills/custom/pill32128-1/carbidopa-and-levodopa-extended-release.jpeg)
SG 461
Carbidopa and Levodopa Extended-Release
- Strength
- 50 mg / 200 mg
- Imprint
- SG 461
- Color
- Blue
- Shape
- Oval
![Pill barr 158 Green & Yellow Capsule/Oblong is Chlordiazepoxide Hydrochloride](https://www.drugs.com/images/pills/nlm/200000892.jpg)
1 / 3
Loading
barr 158
Chlordiazepoxide Hydrochloride
- Strength
- 5 mg
- Imprint
- barr 158
- Color
- Green & Yellow
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.